State Street
NPCE icon

State Street’s Neuropace NPCE Stock Holding History

State Street’s Portfolio NPCE Stock Details NPCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.74M Buy
550,132
+52,586
+11% +$846K ﹤0.01% 2752
2026
Q1 		$6.54M Buy
497,546
+49,682
+11% +$745K ﹤0.01% 2823
2025
Q4 		$6.92M Buy
447,864
+40,025
+10% +$535K ﹤0.01% 2830
2025
Q3 		$4.2M Buy
407,839
+39,102
+11% +$369K ﹤0.01% 3056
2025
Q2 		$4.11M Buy
368,737
+196,882
+115% +$2.46M ﹤0.01% 3027
2025
Q1 		$2.11M Buy
171,855
+23,552
+16% +$295K ﹤0.01% 3225
2024
Q4 		$1.66M Sell
148,303
-7,187
-5% -$62.5K ﹤0.01% 3376
2024
Q3 		$1.08M Buy
155,490
+12,912
+9% +$94.4K ﹤0.01% 3467
2024
Q2 		$1.08M Buy
142,578
+105,327
+283% +$1.06M ﹤0.01% 3462
2024
Q1 		$492K Buy
37,251
+3,900
+12% +$55.6K ﹤0.01% 3653
2023
Q4 		$344K Buy
33,351
+100
+0.3% +$797 ﹤0.01% 3734
2023
Q3 		$324K Buy
33,251
+10,800
+48% +$63.2K ﹤0.01% 3784
2023
Q2 		$101K Hold
22,451
– – ﹤0.01% 4236
2023
Q1 		$104K Hold
22,451
– – ﹤0.01% 4313
2022
Q4 		$33.5K Hold
22,451
– – ﹤0.01% 4645
2022
Q3 		$84K Hold
22,451
– – ﹤0.01% 4522
2022
Q2 		$111K Sell
22,451
-76,266
-77% -$504K ﹤0.01% 4482
2022
Q1 		$810K Buy
98,717
+2,042
+2% +$17.6K ﹤0.01% 3871
2021
Q4 		$974K Sell
96,675
-930
-1% -$12.1K ﹤0.01% 3819
2021
Q3 		$1.55M Buy
97,605
+24,799
+34% +$521K ﹤0.01% 3683
2021
Q2 		$1.73M Buy
+72,806
New +$1.69M ﹤0.01% 3570

Other funds holding NPCE

PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

State Street's NPCE Position: Q2 2026 in Review

State Street increased its Neuropace (NPCE) stake by 11% in Q2 2026, buying an estimated $846K and bringing the position to 550,132 shares worth $8.74M. The position accounts for ﹤0.01% of the portfolio, ranked #2752.

State Street first reported a position in NPCE in Q2 2021 and has held it in 21 quarters since. 112 funds tracked by Wall St. Rank hold NPCE as of Q2 2026.

  • State Street held 550,132 shares of Neuropace worth $8.74M as of Q2 2026.
  • State Street bought 52,586 Neuropace shares in Q2 2026, an estimated $846K.
  • Neuropace made up ﹤0.01% of State Street's portfolio in Q2 2026, its #2752 holding.
  • State Street first reported a position in Neuropace in Q2 2021 and has held it in 21 quarters since.
  • 112 funds tracked by Wall St. Rank held Neuropace as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.